Correlation Between Inozyme Pharma and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and X4 Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and X4 Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and X4 Pharmaceuticals
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inozyme and XFOR is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and X4 Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 9.51 times less return on investment than X4 Pharmaceuticals. But when comparing it to its historical volatility, Inozyme Pharma is 1.52 times less risky than X4 Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 98.00 in X4 Pharmaceuticals on October 20, 2024 and sell it today you would lose (47.00) from holding X4 Pharmaceuticals or give up 47.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| X4 Pharmaceuticals |
Inozyme Pharma and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and X4 Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |